Dr. Walter J. Koroshetz was recently named deputy director of the National Institute of Neurological Disorders and Stroke. His appointment began on Jan. 2.
Prior to joining NINDS, Koroshetz was vice-chair of the neurology service and director of stroke and neurointensive care services at Massachusetts General Hospital (MGH). He was also a professor of neurology at Harvard Medical School and has led neurology resident training at MGH since 1990.
"Dr. Koroshetz is an internationally renowned neurologist and outstanding investigator and administrator. His leadership skills and recognized expertise in stroke, imaging, training and neurointensive care will serve the institute well," said NINDS director Dr. Story Landis.
Born in Brooklyn, N.Y., Koroshetz earned his undergraduate degree from Georgetown University in 1975 and his medical degree from the University of Chicago in 1979. He trained in internal medicine at the University of Chicago and MGH, in neurology at MGH and did postdoctoral studies in cellular neurophysiology at MGH and the Harvard neurobiology department. He joined the neurology staff, first in the Huntington's disease unit and then in the stroke and neurointensive care service.
Koroshetz has conducted basic electrophysiology research in cell membranes and in cultures of nerve cells and glial cells (which support nerve cells). His clinical research has focused on finding new treatments for patients with Huntington's disease and stroke. He is the author of more than 100 peer-reviewed publications as well as numerous book chapters and review articles. He has supervised the training of more than 150 residents and fellows.
Koroshetz is no stranger to NINDS. He has served on NINDS intramural review and oversight committees, been involved in various NINDS symposia and clinical trials and served as the institute's representative at the American Neurological Association's Career Development Symposium. He was not only a member of the NINDS-chaired Brain Attack Coalition — a group of professional, voluntary and governmental entities dedicated to reducing the occurrence, disabilities and death associated with stroke — but also led the committee whose work resulted in significantly higher hospital reimbursement for acute ischemic stroke management.
As an NINDS grantee, Koroshetz received funding for laboratory and clinical research projects on Huntington's disease, neuroprotection and translational research in acute stroke.
He is a member of numerous professional societies including the American Academy of Neurology, Society for Neuroscience, Huntington's Disease Society and National Stroke Association. He is associate editor for MRI with the Journal of Neuroimaging and was an associate editor of Cerebrovascular Diseases.
Koroshetz replaces Dr. Audrey Penn, who had served as deputy director since 1995 and is now senior advisor to the NINDS director.